Elevated levels of lipoprotein(a) prompt earlier preventative treatment but clinician response rate remains low
Elevated lipoprotein(a) [Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels >50 mg/dL affecting 20–30% of the global population. Despite therapeutic ...
Mar 16, 2026
0
12









